AURKA, aurora kinase A, 6790

N. diseases: 245; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 Biomarker disease BEFREE These findings implicate AURKA acting as an effective biomarker for BC detection and prognosis, as well as therapeutic target. 30547784 2018
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 Biomarker disease BEFREE These results implicate AURKA as an effective biomarker for bladder cancer detection as well as therapeutic target especially for its basal type. 28102366 2017
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 Biomarker disease BEFREE We evaluated Aurora kinase A, identified as an upregulated candidate molecule in bladder cancer, as a potential therapeutic target. 23403633 2013
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 Biomarker disease BEFREE We retrospectively analyzed amplification of STK15 gene in normal urothelium of 68 patients having undergone radical cystectomy for urothelial bladder carcinoma of the bladder at our department between 1998 and 2006 with available paraffin specimens. 21247708 2011
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 Biomarker disease BEFREE To test the hypothesis that common sequence variants in the cell cycle control pathway may affect bladder cancer susceptibility, the effects of a panel of 10 potential functional single nucleotide polymorphisms (SNPs) from 7 cell cycle control genes, P53, P21, P27, CDK4, CDK6, CCND1, and STK15, were evaluated on bladder cancer risk in a case-control study of 696 bladder cancer cases and 629 healthy controls. 18361427 2008
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 AlteredExpression disease BEFREE Forced overexpression of AURKA in urothelial cells induced amplification of centrosomes, chromosome missegregation, and aneuploidy, and natural overexpression was detectable in in situ lesions from patients with bladder cancer. 18812553 2008
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 Biomarker disease BEFREE Applying STK15 FISH to benign urothelium of bladder cancer patients may help to identify patients at increased risk for adverse clinical outcome. 17786310 2007
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 Biomarker disease BEFREE Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. 15547700 2004
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.090 AlteredExpression disease BEFREE STK15 gene amplification and associated increased expression of the mitotic kinase it encodes are associated with aneuploidy and aggressive clinical behavior in human bladder cancer. 12208897 2002